BlackRock Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.65M | Buy |
57,210
+5,964
| +12% | +$172K | ﹤0.01% | 1548 |
|
|
2016
Q3 | $1.63M | Buy |
51,246
+1,366
| +3% | +$43.4K | ﹤0.01% | 1517 |
|
|
2016
Q2 | $1.62M | Sell |
49,880
-106,771
| -68% | -$3.47M | ﹤0.01% | 1502 |
|
|
2016
Q1 | $4.38M | Sell |
156,651
-167,125
| -52% | -$4.67M | ﹤0.01% | 1122 |
|
|
2015
Q4 | $11.5M | Buy |
323,776
+5,240
| +2% | +$187K | 0.01% | 747 |
|
|
2015
Q3 | $10.5M | Buy |
318,536
+20,100
| +7% | +$665K | 0.01% | 746 |
|
|
2015
Q2 | $12.5M | Buy |
298,436
+215,700
| +261% | +$9.03M | 0.01% | 678 |
|
|
2015
Q1 | $2.7M | Buy |
82,736
+3,525
| +4% | +$115K | ﹤0.01% | 1091 |
|
|
2014
Q4 | $2.52M | Buy |
79,211
+3,919
| +5% | +$124K | ﹤0.01% | 1113 |
|
|
2014
Q3 | $1.86M | Sell |
75,292
-481,144
| -86% | -$11.9M | ﹤0.01% | 1165 |
|
|
2014
Q2 | $12.6M | Sell |
556,436
-28,105
| -5% | -$635K | 0.01% | 701 |
|
|
2014
Q1 | $14.2M | Buy |
584,541
+70,122
| +14% | +$1.71M | 0.01% | 653 |
|
|
2013
Q4 | $12.9M | Sell |
514,419
-550,090
| -52% | -$13.7M | 0.01% | 695 |
|
|
2013
Q3 | $29.2M | Sell |
1,064,509
-1,478,400
| -58% | -$40.6M | 0.03% | 455 |
|
|
2013
Q2 | $46.2M | Buy |
+2,542,909
| New | +$46.2M | 0.05% | 331 |
|